Unknown

Dataset Information

0

MicroRNAs in the epigenetic regulation of disease progression in Parkinson's disease.


ABSTRACT: Parkinson's disease (PD) is a multifactorial neurodegenerative condition with symptoms such as resting tremor, rigidity, bradykinesia (slowness of moment), and postural instability. Neuroinflammation plays a significant part in the onset and progression of neurodegeneration in a wide range of disorders, including PD. The loss of dopaminergic neurons in the substantia nigra (SN) is thought to be the primary cause of PD disease progression. However, other neurotransmitter systems like serotoninergic, glutamatergic, noradrenergic, adrenergic, cholinergic, tryptaminergic, and peptidergic appear to be affected as well. Epigenetic regulation of gene expression is emerging as an influencing factor in the pathophysiology of PD. In recent years, epigenetic regulation by microRNAs (miRNAs) has been discovered to play an important function in the disease progression of PD. This review explores the role of miRNAs and their signaling pathways in regulating gene expression from development through neurodegeneration and how these mechanisms are linked to the pathophysiology of PD, emphasizing potential therapeutic interventions.

SUBMITTER: Selvakumar SC 

PROVIDER: S-EPMC9524246 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature

altmetric image

Publications

MicroRNAs in the epigenetic regulation of disease progression in Parkinson's disease.

Selvakumar Sushmaa Chandralekha SC   Preethi K Auxzilia KA   Tusubira Deusdedit D   Sekar Durairaj D  

Frontiers in cellular neuroscience 20220916


Parkinson's disease (PD) is a multifactorial neurodegenerative condition with symptoms such as resting tremor, rigidity, bradykinesia (slowness of moment), and postural instability. Neuroinflammation plays a significant part in the onset and progression of neurodegeneration in a wide range of disorders, including PD. The loss of dopaminergic neurons in the substantia nigra (SN) is thought to be the primary cause of PD disease progression. However, other neurotransmitter systems like serotoninerg  ...[more]

Similar Datasets

| S-EPMC5026906 | biostudies-literature
| S-EPMC9076404 | biostudies-literature
| S-EPMC3163813 | biostudies-literature
| S-EPMC4201574 | biostudies-literature
| S-EPMC6525811 | biostudies-literature
| S-EPMC9963946 | biostudies-literature
| S-EPMC6888719 | biostudies-literature
| S-EPMC5976687 | biostudies-literature
| S-EPMC3792848 | biostudies-literature
| S-EPMC9522289 | biostudies-literature